[Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam)

October 21, 2022

Up to $150,000 per award; budget may vary based on request and available funds.

Supports independent medical education initiatives that advance knowledge and best practices in transthyretin amyloidosis (ATTR), acute hepatic porphyria (AHP), or primary hyperoxaluria type 1 (PH1).

Only organizations (not individuals) may apply; ACCME accreditation required for medical education providers.

--- ## Description Alnylam Pharmaceuticals issues Requests for Proposals (RFPs) throughout the year to invite eligible organizations to submit proposals for independent medical education activities. These grants are intended to address unmet educational needs and improve patient outcomes in Alnylam’s core therapeutic areas: transthyretin-mediated amyloidosis (ATTR amyloidosis), acute hepatic porphyria (AHP), and primary hyperoxaluria type 1 (PH1). Grantees are responsible for the design, execution, and compliance of their initiatives, which must align with the specifications of each RFP and adhere to all legal and regulatory requirements. Alnylam maintains strict independence and does not receive any tangible business benefit from supported programs. --- ## Due Dates - October 21, 2022: Submission deadline for RFP ALNY-RFP-TTR-12 (Transthyretin Amyloidosis) --- ## Funding Amount - Individual requests of up to $150,000 USD will be considered. - Actual funding may differ from the amount requested; multiple sources of support are encouraged. - Funds may not be used for meals for attendee healthcare professionals. - Budget must be reasonable, customary, and within fair market value for the activity. --- ## Eligibility - Eligible applicants include: - Professional associations - Patient advocacy organizations - Healthcare institutions - Medical education companies (must be ACCME-accredited, with the requestor as the accredited provider) - Ineligible applicants: - Individuals - Healthcare provider practice groups - Healthcare provider-owned clinics - Managed care organizations - Pharmacy benefit managers - Activities must be accredited by appropriate accrediting bodies (e.g., ACCME) and comply with all relevant standards. - Proof of valid, government-issued tax status is required. --- ## Application Process - Proposals must be submitted electronically in English via the Alnylam grants portal: [https://alnylam-grants.steeprockinc.com/](https://alnylam-grants.steeprockinc.com/) - Submission must occur at least 45 days before the planned activity start date (or by the RFP deadline, if earlier). - Required proposal elements include: - Comprehensive needs assessment/gap analysis - Defined target audience and rationale - Recruitment and engagement strategy - SMART learning objectives - Content accuracy and update plan - Educational design and faculty qualifications - Evaluation and outcomes reporting plan - Detailed budget and justification - Proof of accreditation and conflict of interest policies - All applicants will be notified of funding decisions by email. - If awarded, a formal letter of agreement must be executed electronically. - For CME and non-CME grants, reconciliation (including return of unused funds) is required within 90 days of program end. --- ## Additional Information - Each RFP will specify particular educational objectives, deliverables, target audiences, and reporting requirements. - Programs must ensure transparency regarding Alnylam’s support. - Grant funds may not be used for meals for HCP attendees. - Alnylam reserves the right to request additional information, reject applications, or cancel the RFP at any time. --- ## External Links - [Alnylam Grants and Giving Overview](https://www.alnylam.com/about-alnylam/grants-and-giving#cme-grants) - [Grant Submission Portal](https://alnylam-grants.steeprockinc.com/) - [RFP ALNY-RFP-TTR-12 PDF](https://www.alnylam.com/sites/default/files/pdfs/ALNY-RFP-TTR-12.pdf) --- ## Contact Information | Contact | Details | |------------------------|----------------------------------------------------------------| | Grants Office Email | [grants@alnylam.com](mailto:grants@alnylam.com) | | Submission Portal | [https://alnylam-grants.steeprockinc.com/](https://alnylam-grants.steeprockinc.com/) | | Funder Website | [Alnylam Pharmaceuticals](https://www.alnylam.com/about-alnylam) |

Responses to Requests for Proposals

Sign in to see full grant listing